hotspot
Previous article:
Novavax promises a turnaround & Lilly roils the obesity market
Next article: JPM 2024 Day 3: Biotech Updates from Verve, Roivant, etc
Next article: JPM 2024 Day 3: Biotech Updates from Verve, Roivant, etc
knowledge
focus
-
Antibiotic resistance and the global rise in human conflict
2025-08-23 05:40 -
GSK Flovent asthma inhalers replaced by authorized generics
2025-08-23 05:32 -
Antibiotic resistance and the global rise in human conflict
2025-08-23 05:08 -
At JPM, Bristol Myers Squibb CEO tries to soothe investor nerves
2025-08-23 05:03 -
Nick Leschly quits Bluebird Bio spinout amid restructuring, layoffs
2025-08-23 04:24 -
Feng Zhang, Grail founder join forces on new gene editing startup
2025-08-23 04:20